Skip to main content
Clinical Trials/CTRI/2022/12/048635
CTRI/2022/12/048635Not yet recruitingPhase 2/3

Randomized controlled clinical trial to compare erandmool-amlak churna with neosporin powder in umbilical cord care.

Tilak Ayurved Mahavidyalaya ,Pune1 site in 1 country60 target enrollmentStarted: February 1, 2023Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Fall of umbilical cord without any inflammation and discharge.

Study Overview

Brief Summary

Neonatal sepsis is the most important cause of morbidity and mortality.Though modern medicine is progressive but drugs used in umbilical sepsis in neonates has too much side effects so to establish the importance of Ayurvedic concepts and remedies related to Nabhinal paricharya,this study is selected.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Open Label

Eligibility Criteria

Ages
1.00 Day(s) to 28.00 Day(s) (—)
Sex
All

Inclusion Criteria

  • All Full term neonates Willing of parents.

Exclusion Criteria

  • Neonates having pain or swelling or any inflammation sign at umbilical region.
  • Neonates admitted in NICU.
  • Non willing parents.
  • Neonates having congenital defects or who have been resuscitated.

Outcomes

Primary Outcomes

Fall of umbilical cord without any inflammation and discharge.

Time Frame: baseline,3days,5days,7days,15days.

Secondary Outcomes

  • Serous or any other discharge , inflammation after falling of umbilical cord.(15 days)

Investigators

Sponsor
Tilak Ayurved Mahavidyalaya ,Pune
Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials